These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 32104254)

  • 1. Doppler ultrasound and photoplethysmographic assessment for identifying pregnancy-induced hypertension.
    Sun X; Su F; Chen X; Peng Q; Luo X; Hao X
    Exp Ther Med; 2020 Mar; 19(3):1955-1960. PubMed ID: 32104254
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The use of angiogenic biomarkers in maternal blood to identify which SGA fetuses will require a preterm delivery and mothers who will develop pre-eclampsia.
    Chaiworapongsa T; Romero R; Whitten AE; Korzeniewski SJ; Chaemsaithong P; Hernandez-Andrade E; Yeo L; Hassan SS
    J Matern Fetal Neonatal Med; 2016; 29(8):1214-28. PubMed ID: 26303962
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Contingent screening for preterm pre-eclampsia.
    Wright D; Gallo DM; Gil Pugliese S; Casanova C; Nicolaides KH
    Ultrasound Obstet Gynecol; 2016 May; 47(5):554-9. PubMed ID: 26643929
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impaired placentation in women with chronic hypertension who develop pre-eclampsia.
    Panaitescu AM; Akolekar R; Kametas N; Syngelaki A; Nicolaides KH
    Ultrasound Obstet Gynecol; 2017 Oct; 50(4):496-500. PubMed ID: 28470791
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Maternal plasma soluble endoglin at 11-13 weeks' gestation in pre-eclampsia.
    Foidart JM; Munaut C; Chantraine F; Akolekar R; Nicolaides KH
    Ultrasound Obstet Gynecol; 2010 Jun; 35(6):680-7. PubMed ID: 20205159
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Repeat measurements of uterine artery pulsatility index, mean arterial pressure and serum placental growth factor at 12, 22 and 32 weeks in prediction of pre-eclampsia.
    Andrietti S; Carlucci S; Wright A; Wright D; Nicolaides KH
    Ultrasound Obstet Gynecol; 2017 Aug; 50(2):221-227. PubMed ID: 28078815
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Management of pregnancies after combined screening for pre-eclampsia at 19-24 weeks' gestation.
    Litwinska M; Syngelaki A; Wright A; Wright D; Nicolaides KH
    Ultrasound Obstet Gynecol; 2018 Sep; 52(3):365-372. PubMed ID: 29943498
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Competing-risks model in screening for pre-eclampsia in twin pregnancy according to maternal factors and biomarkers at 11-13 weeks' gestation.
    Francisco C; Wright D; Benkő Z; Syngelaki A; Nicolaides KH
    Ultrasound Obstet Gynecol; 2017 Nov; 50(5):589-595. PubMed ID: 28556556
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Correlation between uterine artery Doppler and the sFlt-1/PlGF ratio in different phenotypes of placental dysfunction.
    Fabjan-Vodusek V; Kumer K; Osredkar J; Verdenik I; Gersak K; Premru-Srsen T
    Hypertens Pregnancy; 2019 Feb; 38(1):32-40. PubMed ID: 30485134
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A quantitative investigation of hemodynamic adaptation to pregnancy using uterine artery Doppler ultrasonography and finger photoplethysmography.
    Han N; Luo X; Su F
    Hypertens Pregnancy; 2014 Nov; 33(4):498-507. PubMed ID: 25121568
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma soluble endoglin concentration in pre-eclampsia is associated with an increased impedance to flow in the maternal and fetal circulations.
    Chaiworapongsa T; Romero R; Kusanovic JP; Mittal P; Kim SK; Gotsch F; Than NG; Mazaki-Tovi S; Vaisbuch E; Erez O; Yeo L; Hassan SS; Sorokin Y
    Ultrasound Obstet Gynecol; 2010 Feb; 35(2):155-62. PubMed ID: 20101637
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Maternal endothelial function and serum concentrations of placental growth factor and soluble endoglin in women with abnormal placentation.
    Savvidou MD; Noori M; Anderson JM; Hingorani AD; Nicolaides KH
    Ultrasound Obstet Gynecol; 2008 Dec; 32(7):871-6. PubMed ID: 18814185
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Uterine artery Doppler and sFlt-1/PlGF ratio: usefulness in diagnosis of pre-eclampsia.
    Gómez-Arriaga PI; Herraiz I; López-Jiménez EA; Gómez-Montes E; Denk B; Galindo A
    Ultrasound Obstet Gynecol; 2013 May; 41(5):530-7. PubMed ID: 23303638
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biomarkers of impaired placentation at 35-37 weeks' gestation in the prediction of adverse perinatal outcome.
    Ciobanou A; Jabak S; De Castro H; Frei L; Akolekar R; Nicolaides KH
    Ultrasound Obstet Gynecol; 2019 Jul; 54(1):79-86. PubMed ID: 31100188
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prediction of early and late pre-eclampsia from maternal characteristics, uterine artery Doppler and markers of vasculogenesis during first trimester of pregnancy.
    Parra-Cordero M; Rodrigo R; Barja P; Bosco C; Rencoret G; Sepúlveda-Martinez A; Quezada S
    Ultrasound Obstet Gynecol; 2013 May; 41(5):538-44. PubMed ID: 22807133
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessment of uterine artery geometry and hemodynamics in human pregnancy with 4d flow mri and its correlation with doppler ultrasound.
    Hwuang E; Vidorreta M; Schwartz N; Moon BF; Kochar K; Tisdall MD; Detre JA; Witschey WRT
    J Magn Reson Imaging; 2019 Jan; 49(1):59-68. PubMed ID: 30390347
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Uterine artery pulsatility index at 12, 22, 32 and 36 weeks' gestation in screening for pre-eclampsia.
    O'Gorman N; Tampakoudis G; Wright A; Wright D; Nicolaides KH
    Ultrasound Obstet Gynecol; 2016 May; 47(5):565-72. PubMed ID: 26582756
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Uterine artery Doppler and sFlt-1/PlGF ratio: prognostic value in early-onset pre-eclampsia.
    Gómez-Arriaga PI; Herraiz I; López-Jiménez EA; Escribano D; Denk B; Galindo A
    Ultrasound Obstet Gynecol; 2014 May; 43(5):525-32. PubMed ID: 24185845
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prediction of small-for-gestational-age neonates: screening by biophysical and biochemical markers at 30-34 weeks.
    Bakalis S; Peeva G; Gonzalez R; Poon LC; Nicolaides KH
    Ultrasound Obstet Gynecol; 2015 Oct; 46(4):446-51. PubMed ID: 25826154
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prediction of early- and late-onset pregnancy-induced hypertension using placental volume on three-dimensional ultrasound and uterine artery Doppler.
    Arakaki T; Hasegawa J; Nakamura M; Hamada S; Muramoto M; Takita H; Ichizuka K; Sekizawa A
    Ultrasound Obstet Gynecol; 2015 May; 45(5):539-43. PubMed ID: 25042564
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.